This author has yet to write their bio.Meanwhile lets just say that we are proud Caitlin Osterman contributed a whooping 90 entries.
The Problem: The current global disease control strategy is focused almost entirely on responding to pandemics after they have emerged, leaving the global community vulnerable to rising human health threats. The emergence of Ebola and the Middle East Respiratory Syndrome serve as poignant examples. Considering the speed at which these types of infectious diseases can […]
Vysnova Partners, Inc. awarded the Southeast Asia Biosurveillance and Epidemiology Research (SABER) II Program Landover, MD September 13, 2018 – Vysnova Partners, a global health project management firm, was recently awarded the Southeast Asia Biosurveillance and Epidemiology Research (SABER) II program to provide support for the Naval Medical Research Unit 2 (NAMRU-2) based in […]
Vysnova Partners, Inc. Ranks No. 7 on the 2018 Washington Business Journal’s Fastest 75 with a 3-year Average Revenue Change of 117% Percent WASHINGTON, D.C., November 01, 2018 – Washington Business Journal announced at their 75 Fastest Growing Companies® awards that Vysnova Partners, Inc. (Vysnova) is No. 7 on its Fastest Growing Companies ranking. Vysnova also […]
The Problem: Zika Virus (ZIKV) was declared a global health threat in 2016. Although most of the cases can be attributed to infected bites of Aedes aegypti and Aedes albopictus mosquitoes, a proportion of new Zika infections are due to sexual transmission from infected males to their partners. ZIKV infection features general symptoms such as […]
Vysnova Partners, Inc. Ranks No. 1,211 on the 2018 Inc. 5000 With Three-Year Revenue Growth of 399% NEW YORK, August 15, 2018 – Inc. magazine today revealed that Vysnova Partners, Inc. (Vysnova) is No. 1,211 on its 37th annual Inc. 5000, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents […]
The Problem: The recent Ebola and Zika epidemics have shown just how vital health sector data is in anticipating, monitoring, and responding to health threats. With varying levels of access to healthcare and limited health records in countries where it matters most, it is not an easy task to collect accurate health data across the […]
SEPT 2018 – Vysnova Partners, Inc. (Vysnova) just announced the opening of Vysnova Partners Singapore Branch (VPSB) a local branch located at AXA Tower, 8 Shenton Way, Level 34-01, Singapore. The primary focus of this regional branch office is to enhance our ability to support our program management and medical research services in the region. […]
Vysnova joins the U.S. Naval Medical Research Center Asia, CDC, WHO and 100s of partner organizations in promoting this year’s World Malaria Day Theme, Ready to Beat Malaria. This theme underscores the commitment of the global malaria community in uniting around the common goal of a world free of malaria. Vysnova is proud to support […]
Vysnova Partners celebrates African American History Month by honoring the many African American health pioneers and the impact they have had on healthcare and health research. From Dr. Patricia Bath, the first African American female physician awarded a patent for a medical invention and a current advocate of telemedicine and emerging technology in medical diagnosis […]
Tuesday, January 9, WHITE HOUSE – Vysnova Partners CEO and President, Carlos Rivera, and fellow members of the Small Business Association for International Companies (SBAIC) met with Deputy Assistant to the President and Deputy Director for the White House Office of Public Liaison Stephen Munisteri, and the U.S. Global Leadership Coalition (USGLC). As current chair […]
